CBUS$1.925
Chart
Performance
Key Stats
AI CBUS Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
HoldCibus, Inc. operates in the promising agricultural biotechnology sector, leveraging gene editing technology. However, current financial performance indicates significant losses and negative cash flow, with a high burn rate. While the long-term thematic potential is strong, the company's current financial health and recent significant stock price decline warrant a cautious approach.
Thematic
Cibus is positioned to benefit from the growing demand for sustainable agriculture, reduced chemical usage, and the development of low-carbon plant products through its gene editing technology. The focus on both trait productivity and sustainable ingredients addresses key global agricultural challenges.
Fundamental
Financially, Cibus is in a challenging phase. It shows minimal revenue, substantial operating losses, and a significant negative free cash flow. The company's cash position is dwindling, and the burn rate is high, suggesting a need for future funding or a significant shift in operational efficiency.
Technical
Recent price action and technical indicators suggest a strong downtrend. The stock has experienced significant price drops over various periods, and most short-to-medium term moving averages indicate selling pressure. The MACD and RSI also suggest bearish momentum.
| Factor | Score |
|---|---|
| Sustainable Agriculture Trends | 90 |
| Biotechnology Innovation | 85 |
| Low-Carbon Solutions | 70 |
| Company Rebranding | 65 |
| Regulatory Landscape for Gene Editing | 55 |
| Factor | Score |
|---|---|
| Valuation | 20 |
| Profitability | 5 |
| Growth | 70 |
| Balance Sheet Health | 30 |
| Cash Flow | 10 |
| Factor | Score |
|---|---|
| Trend Analysis | 20 |
| Momentum | 40 |
| Volume Confirmation | 40 |
| Support & Resistance | 30 |
| MACD | 30 |
AI Investing Checklist
Powered by LiveAIBullish Points (5)
Low Price-to-Sales Ratio
The current Price-to-Sales (P/S) ratio is 20.6, which, while seemingly high, should be considered in the context of a growth-oriented biotechnology company. Examining the historical P/S trend for CBUS is crucial. The trailing P/S of 20.6 is lower than the previous year's 42.9, indicating potential improvement or a market re-evaluation.
Focus on Gene Editing Technology
Cibus Inc. is an agricultural biotechnology company developing and licensing gene-edited plant traits. This focus on innovative technology in the agricultural sector could offer significant long-term growth potential as the demand for sustainable and productive agriculture increases.
Bearish Points (7)
High Negative Earnings Per Share (EPS)
The company consistently reports significant negative EPS (e.g., -0.74 in Q2 2025, -0.87 in Q1 2025, -12.59 in Q1 2024). A Price-to-Earnings (P/E) ratio is not applicable in its standard form due to losses. The Price-to-Sales (P/S) ratio is high, especially considering the current revenue and losses.
Significant Net Losses
Cibus Inc. has incurred substantial net losses in recent periods (e.g., -$251.39M in 2024Q4, -$267.63M in 2023Q4). The negative net margins (e.g., -5898.4% in 2024Q4) highlight a significant challenge in achieving profitability.
Calendar
August 2025
7
Next Earnings Date
H: $-0.33
A: $-0.33
L: $-0.33
H: 1.26M
A: 1.15M
L: 1.05M
Profile
Cibus, Inc., an agricultural biotechnology company, develops and licenses gene edited plant traits using gene editing technologies to enhance farming productivity or produce renewable low carbon plant products. It focuses on trait productivity in the productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients, which enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was founded in 2001 and is headquartered in San Diego, California.
Seasonals
Price Target
16.38 USD
The 39 analysts offering 1 year price forecasts for CBUS have a max estimate of 25.00 and a min estimate of 2.00.
Debt Level and Coverage
Financial Position Analysis
Ownership
Capital Structure
Valuation - Summary
Valuation - Ratios
Revenue to Profit Conversion
Balance Sheet
Income Statement
Cash Flow
Related Companies
Powered by LiveAIWeight: 98
Building a multi-billion dollar semiconductor fabrication plant in the Columbus metropolitan area, representing a transformative economic investment.
Weight: 95
Operates one of its largest global operations centers in Columbus, serving as a massive employer and economic anchor for the city.
Weight: 92
Headquartered in Columbus, Ohio, and is a major utility provider for the region and beyond.
Weight: 90
Headquartered in Columbus, Ohio, and is a major regional bank with a significant local presence and employer.